Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia in the Elderly
维生素 D 和海洋 Omega-3 脂肪酸对老年人贫血的影响
基本信息
- 批准号:8338289
- 负责人:
- 金额:$ 44.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-05-15 至 2016-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAfrican AmericanAgingAnemiaAnemia due to Chronic DisorderAnti-Inflammatory AgentsAnti-inflammatoryAreaBostonCardiovascular DiseasesCenter for Translational Science ActivitiesCholecalciferolChronicClinicalClinical SciencesClinical TrialsDevelopmentDiagnosisDocosahexaenoic AcidsEicosapentaenoic AcidElderlyEnrollmentErythrocytesErythroidErythropoiesisErythropoietinEthnic OriginGenderHealthcareHemoglobinHigh PrevalenceIncidenceIndividualInflammationInflammatoryInterventionMarinesMeasurementMeasuresMediatingMedical RecordsMorbidity - disease rateNational Health and Nutrition Examination SurveyNot Hispanic or LatinoOmega-3 Fatty AcidsParentsParticipantPathogenesisPathway interactionsPhysiciansPlacebosPopulationPrevalencePrevalence StudyPreventivePrimary Cancer PreventionPropertyQuality of lifeQuestionnairesRaceRandomizedResearchResearch InfrastructureResourcesRiskRoleRunningSamplingScheduleSeasonsSignal TransductionSiteSubgroupSupplementationTestingTimeVitamin DVitamin D DeficiencyWomanactive methodagedcardiovascular risk factorcohortcostcost effectivecytokinedesigndouble-blind placebo controlled trialfollow-upfrailtyglobal healthhepcidinimprovedindexingmenmortalitynovel therapeuticspost interventionracial and ethnic disparities
项目摘要
DESCRIPTION (provided by applicant): We propose to evaluate the impact of vitamin D3 (2,000 IU/day) and marine omega-3 fatty acids (1gm/d eicosapentaenoic acid [EPA]+840mg/d docosahexaenoic acid [DHA], in a 1.3:1 ratio), which have anti- inflammatory properties, on erythropoietic cell signaling and the development of anemia in the elderly in the setting of the newly launched VITamin D and OmegA-3 TriaL (VITAL). Anemia of any degree is recognized as a significant independent contributor to morbidity, mortality, and frailty in the elderly. Furthermore, race appears to be an important variable affecting anemia prevalence, with African-Americans displaying significantly higher rates of anemia than whites. As the number of elderly individuals is expected to reach unprecedented levels in the 21st century, anemia represents an emerging global health problem negatively impacting quality of life in the elderly population and requiring ever increasing allocation of health care resources. The pathogenesis of anemia in the elderly remains poorly studied and, as a consequence, there is a lack of proven preventive therapies. We recently showed that vitamin D deficiency is independently associated with a higher prevalence of anemia in the elderly, particularly among those with anemia of inflammation. We will take advantage of the VITAL study, a randomized, double-blind, placebo-controlled trial analyzing the role of vitamin D3 and marine omega-3 fatty acid (?-3 FA) supplements in the primary prevention of cancer and cardiovascular disease among 20,000 US men and women aged > 60 and > 65 years, respectively, to test the hypothesis that these interventions will ameliorate the development of anemia in the elderly. In addition, using a sub-sample of the VITAL cohort, we will investigate whether vitamin D and/or ?-3 FA influence erythropoiesis via hepcidin- and/or erythropoietin (EPO)-dependent pathways. We aim to determine whether vitamin D and/or w-3 FA supplements reduce the incidence of diagnosed anemia through the use of medical record review and supplementary questionnaires completed by participants' physicians. In our sub-study, fresh samples will be collected pre- and post-intervention from 900 subjects who will be evaluated at the Boston Clinical and Translational Science Center (CTSC). Using serial measurements of hemoglobin (HgB), red blood cell (RBC) indices, hepcidin, and erythropoietin, we will determine whether vitamin D and/or w-3 FA moderate inflammation-mediated effects on Hgb levels and erythropoietic pathways. The research infrastructure of the parent VITAL trial will provide a unique and cost-effective framework that will allow us to examine the potential benefits of vitamin D and/or w-3 FA supplementation in decreasing anemia in an elderly population. In order to complete baseline (pre-randomization) assessments of Hgb and erythropoietic pathways on fresh samples that will be collected from participants at the Boston CTSC site, it is critically important that this proposl begin in parallel to the 1-year enrollment period for the parent VITAL trial (1U01CA138962), scheduled to begin November 2011.
描述(由申请人提供):我们建议在最新启动的维生素D和omega-3试验(VITAL)的背景下,评估具有抗炎特性的维生素D3(每天2,000IU)和海洋omega-3脂肪酸(1gm/d二十碳五烯酸[EPA]+840 mg/d二十二碳六烯酸[DHA])对红细胞信号和老年人贫血发展的影响。任何程度的贫血都被认为是老年人发病率、死亡率和虚弱的重要独立因素。此外,种族似乎是影响贫血患病率的一个重要变量,非洲裔美国人的贫血率明显高于白人。随着21世纪老年人口数量预计将达到前所未有的水平,贫血是一个新出现的全球健康问题,对老年人口的生活质量产生负面影响,需要不断增加的卫生保健资源分配。老年人贫血的发病机制研究仍然很少,因此,缺乏经过验证的预防性治疗。我们最近发现,维生素D缺乏与老年人贫血的高患病率独立相关,尤其是在患有炎症性贫血的老年人中。我们将利用VITAL研究,这是一项随机、双盲、安慰剂对照试验,分析维生素D3和海洋omega-3脂肪酸(?-3 FA)补充剂在癌症和心血管疾病一级预防中的作用,分别对20,000名年龄分别为60岁和65岁的美国男性和女性进行测试,以检验这些干预措施将改善老年人贫血发展的假设。此外,使用重要队列的一个子样本,我们将调查维生素D和/或?-3FA是否通过海普西丁和/或促红细胞生成素(EPO)依赖的途径影响红细胞生成。我们的目标是通过使用病历回顾和参与者医生填写的补充问卷来确定维生素D和/或w-3FA补充剂是否可以降低被诊断为贫血的发生率。在我们的子研究中,新鲜样本将在干预前和干预后从900名受试者中收集,这些受试者将在波士顿临床和翻译科学中心(CTSC)接受评估。通过对血红蛋白(HGB)、红细胞(RBC)指数、海普西丁和促红细胞生成素的一系列测量,我们将确定维生素D和/或w-3FA是否对HGB水平和红细胞生成途径具有温和的炎症中介作用。Parent VITAL试验的研究基础设施将提供一个独特且具有成本效益的框架,使我们能够研究补充维生素D和/或w-3FA在减少老年人群贫血方面的潜在好处。为了完成从波士顿CTSC现场的参与者那里收集的新鲜样本上的HGB和红细胞生成途径的基线(随机化前)评估,至关重要的是,这项提议与定于2011年11月开始的为期1年的Parent VITAL试验(1U01CA138962)的登记期同步开始。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NANCY BERLINER其他文献
NANCY BERLINER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NANCY BERLINER', 18)}}的其他基金
Targeting the NuRD complex for fetal globin induction
靶向 NuRD 复合物诱导胎儿珠蛋白
- 批准号:
9565568 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Targeting the NuRD complex for fetal globin induction
靶向 NuRD 复合物诱导胎儿珠蛋白
- 批准号:
9214505 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Targeting the NuRD complex for fetal globin induction
靶向 NuRD 复合物诱导胎儿珠蛋白
- 批准号:
10000124 - 财政年份:2016
- 资助金额:
$ 44.63万 - 项目类别:
Effects of Vitamin D and Marine Omega-3 Fatty Acids on Anemia in the Elderly
维生素 D 和海洋 Omega-3 脂肪酸对老年人贫血的影响
- 批准号:
8468735 - 财政年份:2012
- 资助金额:
$ 44.63万 - 项目类别:
相似海外基金
Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods
对投资撤资的非裔美国人社区的社区劣势、认知老化和阿尔茨海默病风险进行纵向调查
- 批准号:
10370185 - 财政年份:2022
- 资助金额:
$ 44.63万 - 项目类别:
Longitudinal Examination of Neighborhood Disadvantage, Cognitive Aging, and Alzheimer's Disease Risk in Disinvested, African American Neighborhoods
对投资撤资的非裔美国人社区的社区劣势、认知老化和阿尔茨海默病风险进行纵向调查
- 批准号:
10565869 - 财政年份:2022
- 资助金额:
$ 44.63万 - 项目类别:
Diversity Supplement to Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women
对非裔美国女性因 COVID-19 和血管老化造成的心理社会压力进行多样性补充
- 批准号:
10709289 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Psychosocial Stress Due to COVID-19 and Vascular Aging in African-American Women
COVID-19 造成的心理社会压力和非裔美国女性的血管老化
- 批准号:
10792341 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women
COVID-19 造成的心理社会压力和非裔美国女性的血管老化
- 批准号:
10604282 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Diversity Supplement to Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women
对非裔美国女性因 COVID-19 和血管老化造成的心理社会压力进行多样性补充
- 批准号:
10833229 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Psychosocial Stress due to COVID-19 and Vascular Aging in African-American Women
COVID-19 造成的心理社会压力和非裔美国女性的血管老化
- 批准号:
10396097 - 财政年份:2021
- 资助金额:
$ 44.63万 - 项目类别:
Origin of Chronic Diseases of Aging Among Rural African American Young Adults
农村非裔美国年轻人慢性衰老疾病的起源
- 批准号:
9925262 - 财政年份:2018
- 资助金额:
$ 44.63万 - 项目类别:
Interdisciplinary Lifecourse Approaches to African American Cognitive Aging
非洲裔美国人认知衰老的跨学科生命历程方法
- 批准号:
8549089 - 财政年份:2012
- 资助金额:
$ 44.63万 - 项目类别:
Interdisciplinary Lifecourse Approaches to African American Cognitive Aging
非洲裔美国人认知衰老的跨学科生命历程方法
- 批准号:
8459278 - 财政年份:2012
- 资助金额:
$ 44.63万 - 项目类别: